全外显子组测序后反向表型分析在激素抵抗型肾病综合征中的应用
该回顾性研究纳入2000至2018年间转诊的111例肾病综合征患者(64例激素抵抗型,47例激素敏感型),对指征患者行全外显子组测序并过滤298个慢性肾脏病相关基因,随后进行反向表型分析。激素敏感组未检出致病性变异;激素抵抗组中30%(19/64)存在足细胞病基因致病性变异,另有28%(18/64)通过反向表型分析发现其他基因变异。反向表型分析提高了激素抵抗型肾病综合征的诊断准确性。
要点
- 激素敏感型患者中未检出致病性变异。
- 激素抵抗型患者中30%有足细胞病基因变异。
- 反向表型分析额外识别28%的其他遗传性肾病。
核心结论
- 反向表型分析提高了激素抵抗型肾病综合征患者的诊断准确性。
研究设计与样本
- 回顾性研究纳入2000至2018年间转诊的111例肾病综合征患者,其中激素抵抗型64例、激素敏感型47例。
- 对指征患者行全外显子组测序,并针对298个慢性肾脏病相关基因进行计算机过滤,随后在患者及家系中开展反向表型分析。
- 致病性变异依据美国医学遗传学与基因组学学会现行指南判定。
主要发现
- 激素敏感组未检出任何致病性变异。
- 激素抵抗组中30%(19/64)存在足细胞病基因致病性变异,同时相当数量变异位于不常与孤立性肾病综合征相关的其他基因。
- 基于个体化诊断流程的反向表型分析,在另外28%(18/64)患者中识别出先前未认识到的意外遗传性肾病临床征象。
- 这些患者与遗传性足细胞病相比表现出相似的多药耐药,但长期结局不同。
临床怎么用
- 对激素抵抗型肾病综合征患者,可考虑全外显子组测序结合反向表型分析以提高遗传诊断率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Nephrotic syndrome is a typical presentation of genetic podocytopathies but occasionally other genetic nephropathies can present as clinically indistinguishable phenocopies. We hypothesized that extended genetic testing followed by reverse phenotyping would increase the diagnostic rate for these patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: All patients diagnosed with nephrotic syndrome and referred to our center between 2000 and 2018 were assessed in this retrospective study. When indicated, whole-exome sequencing and in silico filtering of 298 genes related to CKD were combined with subsequent reverse phenotyping in patients and families. Pathogenic variants were defined according to current guidelines of the American College of Medical Genetics. RESULTS: A total of 111 patients (64 steroid-resistant and 47 steroid-sensitive) were included in the study. Not a single pathogenic variant was detected in the steroid-sensitive group. Overall, 30% (19 out of 64) of steroid-resistant patients had pathogenic variants in podocytopathy genes, whereas a substantial number of variants were identified in other genes, not commonly associated with isolated nephrotic syndrome. Reverse phenotyping, on the basis of a personalized diagnostic workflow, permitted to identify previously unrecognized clinical signs of an unexpected underlying genetic nephropathy in a further 28% (18 out of 64) of patients. These patients showed similar multidrug resistance, but different long-term outcome, when compared with genetic podocytopathies. CONCLUSIONS: Reverse phenotyping increased the diagnostic accuracy in patients referred with the diagnosis of steroid-resistant nephrotic syndrome.
引用
- Landini S, Mazzinghi B, Becherucci F, et al. Reverse Phenotyping after Whole-Exome Sequencing in Steroid-Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2019. PMID: 31831576. doi:10.2215/CJN.06060519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。